Clinical Trials Update: Mar. 5, 2003

Clinical Trials Update: Mar. 5, 2003

Source: HealthScoutNews

Here are the latest clinical trials, courtesy of CenterWatch:

Rheumatoid Arthritis

A study to evaluate the efficacy and safety of a COX-2 specific inhibitor in treating symptoms of severe rheumatoid arthritis. Volunteers who are at least 18 years of age, have been diagnosed with rheumatoid arthritis for at least 6 months, and are currently being treated with an NSAID (such as naproxen or ibuprofen) may be eligible to participate. Research sites located throughout the United States.

More Information

Please see http://www.centerwatch.com/patient/studies/cat132.html.

—–

Crohn’s Disease

A study to test the safety and effectiveness of an injectable investigational medication in patients with active Crohn’s disease. Research site located in Charlotte, North Carolina.

More Information

Please see http://www.centerwatch.com/patient/studies/cat51.html.

—–

Depression (Adult and Geriatric)

A research study of an experimental antidepressant drug. Depressed adults age 65 and older are needed to participate. Research site located in Los Angeles, California.

More Information

Please see http://www.centerwatch.com/patient/studies/cat6.html.

—–

Copyright 2003 CenterWatch. All rights reserved.

—-

More news from the world’s of science, space, and technology from RedNova